epirubicin "teva" 2 mg/ml injektions-/infusionsvæske, opløsning
teva b.v. - epirubicinhydrochlorid - injektions-/infusionsvæske, opløsning - 2 mg/ml
palonosetronhydrochlorid "qilu" 50 mikrogram/ml injektionsvæske, opløsning
qilu pharma spain s.l. - palonosetronhydrochlorid - injektionsvæske, opløsning - 50 mikrogram/ml
temozolomid "fair-med" 100 mg kapsler, hårde
fair-med healthcare gmbh - temozolomid - kapsler, hårde - 100 mg
temozolomid "fair-med" 140 mg kapsler, hårde
fair-med healthcare gmbh - temozolomid - kapsler, hårde - 140 mg
temozolomid "fair-med" 180 mg kapsler, hårde
fair-med healthcare gmbh - temozolomid - kapsler, hårde - 180 mg
temozolomid "fair-med" 20 mg kapsler, hårde
fair-med healthcare gmbh - temozolomid - kapsler, hårde - 20 mg
temozolomid "fair-med" 250 mg kapsler, hårde
fair-med healthcare gmbh - temozolomid - kapsler, hårde - 250 mg
temozolomid "fair-med" 5 mg kapsler, hårde
fair-med healthcare gmbh - temozolomid - kapsler, hårde - 5 mg
kimmtrak
immunocore ireland limited - tebentafusp - uveal neoplasms - antineoplastiske midler - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.